Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
73
-
Total shares
-
30.3M
-
Shares change
-
-2.42M
-
Total reported value, excl. options
-
$72.8M
-
Value change
-
-$13.5M
-
Put/Call ratio
-
1.29
-
Number of buys
-
39
-
Number of sells
-
-42
-
Price
-
$2.40
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q4 2018
77 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q4 2018.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.3M shares
.
Largest 10 shareholders include BlackRock Inc. (7.57M shares), STATE STREET CORP (6.05M shares), Vanguard Group Inc (3.61M shares), MORGAN STANLEY (2.19M shares), NORTHERN TRUST CORP (1.26M shares), GEODE CAPITAL MANAGEMENT, LLC (1.05M shares), D. E. Shaw & Co., Inc. (894K shares), CITIGROUP INC (881K shares), RENAISSANCE TECHNOLOGIES LLC (807K shares), and UBS Group AG (695K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.